• GPR35–KLF5 and Intestinal Repair

  2026-10-12

  A 2026 Cell Death & Disease study proposes that GPR35 connects tryptophan metabolism to KLF5-dependent intestinal epithelial repair. The findings offer a mechanistic framework for ulcerative colitis research, while the supplied record leaves important questions about model scope, quantitative evidence, and relevance to human disease.

• What the CYR61–Migrasome Study Shows—and Misses

  2026-10-12

  The supplied 2025 study supports a model in which CYR61-associated migrasomes may help restore migration and osteogenic behavior in irradiated BMSCs, but its findings do not establish clinical efficacy or compare protein-preservation reagents. Product claims for an MS-compatible Protease Inhibitor Cocktail should therefore remain separate from the study’s biological conclusions.

• PRINT: RNA-Mediated Safe-Harbor Insertion

  2026-10-10

  A Nature Biotechnology study introduces PRINT, an RNA-only strategy that uses avian R2 retroelement proteins to direct transgene synthesis into a multicopy human safe-harbor locus. The reported results show substantial insertion of kilobase-scale transgenes in cultured human primary cells, while also defining important limitations around template recognition, junction verification, and transferability beyond the tested model.

• Entecavir and HBV Resistance: Meta-Analysis Findings

  2026-10-09

  Lumley and colleagues provide the first systematic review and meta-analysis to pool sequence-defined hepatitis B virus resistance estimates for entecavir and tenofovir over time. The analysis found low cumulative resistance to entecavir in treatment-naive populations, substantially higher resistance among nucleos(t)ide-experienced participants, and no pooled tenofovir resistance signal—although important evidence gaps limit interpretation.

• Sodium Chloride B7288: Product Overview

  2026-10-09

  Sodium chloride B7288 is a supplier-listed inorganic salt with the identity NaCl, molecular weight 58.44, CAS 7647-14-5, and stated purity of 98%. No matched paper evidence is available for this specific product.

• Uridine, Trisodium Salt: Evidence and Scope

  2026-10-08

  Explore Uridine, Trisodium Salt as a biochemical reagent for RNA metabolism and vascular research, while separating its established biochemical relevance from the RNA-only PRINT genome-engineering findings reported in Nature Biotechnology.

• Carbenoxolone Disodium: Product Overview

  2026-10-08

  Carbenoxolone disodium (SKU A8389) is listed by APExBIO as a research compound associated with 11β-hydroxysteroid dehydrogenase, gap junction communication, and related glucocorticoid signaling. No matched paper evidence was provided, so performance, selectivity, and disease-model relevance cannot be independently assessed.

• High-Yield Rabbit Pharming: What the Study Shows

  2026-10-07

  Song et al. developed a targeted rabbit knock-in line that uses the CSN2 regulatory region to drive milk-associated expression of the tdTomato reporter. Homozygous animals reportedly reached 15–20 g/L in milk, supporting targeted promoter selection as a promising strategy, although the study remains an early platform demonstration rather than proof of therapeutic-product performance.

• Toremifene Citrate: Evidence from the Reference Paper

  2026-10-07

  The reference paper presents Toremifene Citrate as a nonsteroidal antiestrogen and oral selective estrogen receptor modulator for hormone receptor-positive or unknown-status advanced breast cancer in postmenopausal women. Its principal contribution is a clinically oriented synthesis connecting estrogen receptor pharmacology with comparative efficacy, safety monitoring, drug interactions, and oncology nursing considerations.

• D-Mannitol B2090: Product Overview

  2026-10-06

  D-Mannitol B2090 is a supplier-described biochemical reagent for conceptual osmotic regulation research, renal function studies, and diuretic mechanism investigation. No matched paper evidence was provided for this specific product.

• Leucovorin Calcium in Gastric Cancer Models

  2026-10-06

  Leucovorin Calcium, or calcium folinate, is relevant to research on reduced folate biology and methotrexate response. A 2025 gastric cancer assembloid study shows why stromal context can change drug sensitivity, but it does not directly establish leucovorin-specific effects or clinical utility.

• Uridine, Trisodium Salt: What the Evidence Shows

  2026-10-05

  Uridine, Trisodium Salt is examined here as a nucleoside analog within RNA metabolism, vascular biology, and RNA-mediated genome engineering. Rather than treating a commercial reagent as proof of platform performance, this evidence-led analysis separates supplier specifications from what PRINT research actually demonstrated.

• Sodium Phosphate Dibasic: Evidence and Limits

  2026-10-05

  Sodium phosphate dibasic, or Na2HPO4, is a water-soluble phosphate salt used for pH control in biochemical and molecular biology contexts. Its buffering role can support assay consistency, but it is not direct evidence for the toxicity, efficacy, or ecological behavior of sulfamonomethoxine.

• Gastric Cancer Assembloids and Stromal Drug Response

  2026-10-04

  Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids that combine matched tumor organoids with stromal subpopulations from the same tumor tissue. Their findings show that stromal composition can alter gene expression and drug sensitivity, supporting more physiologically relevant studies of tumor–microenvironment interactions and treatment resistance.

• Sodium Citrate in 3D SERS Evidence

  2026-10-03

  Explore how sodium citrate may intersect with reproducible 3D SERS nanostructures without confusing chemical plausibility with demonstrated causation. This evidence-focused analysis examines the reference study, product specifications, research gaps, and responsible interpretation.

7947 records 1/530 page Next 12345 下5页 Last page